The current scientific landscape can best be thought of as a transitional one. With the proliferation of scientific innovation and the role that technology plays in our lives, along with the demand for more of these breakthroughs, comes the simultaneous challenge of balancing affordable lab space, funding and opportunity for young investigators and inventors to shape their companies and test novel projects. Los Angeles science incubator Lab Launch is trying to simplify the process through a revolutionary, not-for-profit approach that serves as a proof of concept for an eventual interconnected network of “discovery hubs”. Founder Llewelyn Cox sits down with ScriptPhD for an insightful podcast that assesses the current scientific climate, the backdrop that catalyzed Lab Launch, and why alternatives to traditional avenues of research are critical for fueling the 21st Century economy. Continue reading Podcast: Disrupting Incubator Innovation With “Lab Launch”→
“It’s like a war. You don’t know whether you’re going to win the war. You don’t know if you’re going to survive the war. You don’t know if the project is going to survive the war.” The war? Cancer, still one of the leading causes of death despite 40 years passing since the National Cancer Act of 1971 catapulted Richard Nixon’s famous “War on Cancer.” The speaker of the above quote? A scientist at Genentech, a San Francisco-based biotechnology and pharmaceutical company, describing efforts to pursue a then-promising miracle treatment for breast cancer facing numerous obstacles, not the least of which was the patients’ rapid illness. If it sounds like a made-for-Hollywood story, it is. But I Want So Much To Live is no ordinary documentary. It was commissioned as an in-house documentary by Genentech, a rarity in the staid, secretive scientific corporate world. The production values and storytelling offer a tremendous template for Hollywood filmmakers, as science and biomedical content become even more pervasive in film. Finally, the inspirational story behind Herceptin, one of the most successful cancer treatments of all time, offers a testament and rare insight to the dedication and emotion that makes science work. Full story and review under the “continue reading” cut. Continue reading From The Lab: Pharmaceutical Documentary a Blueprint for Hollywood Science Storytelling→
How many times have you said to yourself, “If only I didn’t have to sleep.” Or “If only I tap into my brain’s full neuronal capacity, imagine the things I could do?” Such neurocognitive superpowers would seem to be the stuff of science fiction…for now. In the new film “Limitless,” these wishes unexpectedly come true for a struggling writer, but the results—and unexpected side effects—cause him to wonder whether it was all worth it. Sleek, stylish, sexy and well-crafted, “Limitless” is part scientific inquiry into the limits of expanding the pharmacopeia beyond current human capacities and part thriller to see if the main character who dares to try will get away with it. ScriptPhD.com’s full review of Limitless under the “continue reading” cut. Continue reading REVIEW: Limitless→
About a week and a half ago, scientists achieved a remarkable evolutionary stepping stone in the technological holy grail of eventually engineering synthetic life. Nicknamed ‘Synthia’ by her experimental progenitors, the latest discovery is a viable, self-propagating yeast cell hosting a bacterial Mycoplasma mycoides genome (consisting of non-biological DNA) purely composed in the laboratory. In eerily apt timing, Splice, a new science fiction thriller premiering this week, explores the scientific ramifications and bioethical morass encompassing the creation of a human-animal hybrid by a rogue superstar genetics couple. Under the “continue reading” cut, ScriptPhD.com’s review of Splice, discussion of the expanding frontiers of genetic engineering, and a special video interview with the director/writer, producer and stars of the film.